\contentsline {chapter}{Preamble about Interdisciplinary Research}{15}{chapter*.6}
\contentsline {section}{What does interdisciplinarity in science mean in XXI century?}{16}{section*.7}
\contentsline {section}{Strengths, Weaknesses Opportunities, Threats (SWOT) of an interdisciplinary PhD - personal perspective}{19}{section*.10}
\contentsline {section}{General context of the thesis}{22}{section*.12}
\contentsline {section}{Organisation of the dissertation}{22}{section*.13}
\contentsline {chapter}{\numberline {1}Immuno-biology of cancer}{25}{chapter.1}
\contentsline {section}{\numberline {1.1}Cancer disease}{25}{section.1.1}
\contentsline {subsection}{\numberline {1.1.1}Historical understanding of cancer}{26}{subsection.1.1.1}
\contentsline {subsection}{\numberline {1.1.2}Tumor Microenvironment as a complex system}{28}{subsection.1.1.2}
\contentsline {subsubsection}{\numberline {1.1.2.1}Interactions between TME and Tumor}{29}{subsubsection.1.1.2.1}
\contentsline {paragraph}{\numberline {1.1.2.1.1}TME as a foe: inflammation}{30}{paragraph.1.1.2.1.1}
\contentsline {paragraph}{\numberline {1.1.2.1.2}TME seen as neutral}{30}{paragraph.1.1.2.1.2}
\contentsline {paragraph}{\numberline {1.1.2.1.3}TME as a friend: immunosurveillance}{32}{paragraph.1.1.2.1.3}
\contentsline {subsubsection}{\numberline {1.1.2.2}Two-faced nature of immune cells: context-dependent functional plasticity}{33}{subsubsection.1.1.2.2}
\contentsline {subsubsection}{\numberline {1.1.2.3}Immune cell (sub)types in TME}{34}{subsubsection.1.1.2.3}
\contentsline {subsubsection}{\numberline {1.1.2.4}Summary}{35}{subsubsection.1.1.2.4}
\contentsline {section}{\numberline {1.2}Quantifying and qualifying immune infiltration (data)}{36}{section.1.2}
\contentsline {subsection}{\numberline {1.2.1}Cell sorting}{37}{subsection.1.2.1}
\contentsline {subsubsection}{\numberline {1.2.1.1}Flow cytometry}{37}{subsubsection.1.2.1.1}
\contentsline {subsubsection}{\numberline {1.2.1.2}Mass cytometry}{37}{subsubsection.1.2.1.2}
\contentsline {subsection}{\numberline {1.2.2}Microscope Staining}{37}{subsection.1.2.2}
\contentsline {subsection}{\numberline {1.2.3}omics}{38}{subsection.1.2.3}
\contentsline {subsubsection}{\numberline {1.2.3.1}Transcriptome}{38}{subsubsection.1.2.3.1}
\contentsline {subsubsection}{\numberline {1.2.3.2}Single cell RNA-seq}{39}{subsubsection.1.2.3.2}
\contentsline {subsubsection}{\numberline {1.2.3.3}Epigenome}{41}{subsubsection.1.2.3.3}
\contentsline {section}{\numberline {1.3}From cancer phenotyping to immune therapies}{41}{section.1.3}
\contentsline {subsection}{\numberline {1.3.1}Cancer immune phenotypes}{42}{subsection.1.3.1}
\contentsline {subsection}{\numberline {1.3.2}Scoring the immune infiltration}{43}{subsection.1.3.2}
\contentsline {subsubsection}{\numberline {1.3.2.1}Immunoscore}{43}{subsubsection.1.3.2.1}
\contentsline {subsubsection}{\numberline {1.3.2.2}Immunophenoscore}{45}{subsubsection.1.3.2.2}
\contentsline {subsubsection}{\numberline {1.3.2.3}The immune landscape of cancer}{45}{subsubsection.1.3.2.3}
\contentsline {subsubsection}{\numberline {1.3.2.4}A pan-cancer landscape of immune-cancer interactions in solid tumors}{46}{subsubsection.1.3.2.4}
\contentsline {subsubsection}{\numberline {1.3.2.5}Immune maps}{47}{subsubsection.1.3.2.5}
\contentsline {subsubsection}{\numberline {1.3.2.6}Summary}{48}{subsubsection.1.3.2.6}
\contentsline {subsection}{\numberline {1.3.3}Immune signatures - biological perspective}{48}{subsection.1.3.3}
\contentsline {subsection}{\numberline {1.3.4}Cancer therapies}{50}{subsection.1.3.4}
\contentsline {subsection}{\numberline {1.3.5}Recent progress in immuno-therapies}{50}{subsection.1.3.5}
\contentsline {section}{\numberline {1.4}Biological dimension of the thesis}{52}{section.1.4}
\contentsline {chapter}{\numberline {2}Mathematical foundation of cell-type deconvolution of biological data}{55}{chapter.2}
\contentsline {section}{\numberline {2.1}Introduction to supervised and unsupervised learning}{55}{section.2.1}
\contentsline {section}{\numberline {2.2}Cell-type deconvolution models of bulk transcriptome}{57}{section.2.2}
\contentsline {subsection}{\numberline {2.2.1}Literature overview}{57}{subsection.2.2.1}
\contentsline {subsection}{\numberline {2.2.2}Regression-based methods}{59}{subsection.2.2.2}
\contentsline {subsubsection}{\numberline {2.2.2.1}basis matrix}{59}{subsubsection.2.2.2.1}
\contentsline {subsection}{\numberline {2.2.3}regression algorithm}{61}{subsection.2.2.3}
\contentsline {subsection}{\numberline {2.2.4}Enrichment-based methods}{61}{subsection.2.2.4}
\contentsline {subsection}{\numberline {2.2.5}Probabilistic methods}{61}{subsection.2.2.5}
\contentsline {subsection}{\numberline {2.2.6}Convex-hull based methods}{61}{subsection.2.2.6}
\contentsline {subsection}{\numberline {2.2.7}Matrix factorisation methods}{61}{subsection.2.2.7}
\contentsline {subsection}{\numberline {2.2.8}Others aspects}{61}{subsection.2.2.8}
\contentsline {section}{\numberline {2.3}Deconvolution of other data types}{61}{section.2.3}
\contentsline {section}{\numberline {2.4}Methodological dimension of the thesis}{61}{section.2.4}
\contentsline {chapter}{\numberline {3}Study of sensitivity and reproducibility of known methods}{63}{chapter.3}
\contentsline {section}{\numberline {3.1}Finding optimal number of components and over-decomposition of transcriptopmes}{63}{section.3.1}
\contentsline {section}{\numberline {3.2}}{77}{section.3.2}
\contentsline {section}{\numberline {3.3}REPRODUCIBILITY OF NMF VERSUS ICA (VS CAM?)}{77}{section.3.3}
\contentsline {subsection}{\numberline {3.3.1}Comparing metagenes obtained with NMF vs ICA.}{77}{subsection.3.3.1}
\contentsline {section}{\numberline {3.4}Impact of modification of signatures list on result for signature-based deconvolution methods}{80}{section.3.4}
\contentsline {chapter}{\numberline {4}Deconvolution of transcriptomes and methylomes}{81}{chapter.4}
\contentsline {section}{\numberline {4.1}From blind deconvolution to cell-type quantification: general overview}{81}{section.4.1}
\contentsline {subsection}{\numberline {4.1.1}The ICA-based deconvolution of Transcriptomes}{81}{subsection.4.1.1}
\contentsline {subsection}{\numberline {4.1.2}Interpretation of Independent components}{82}{subsection.4.1.2}
\contentsline {subsubsection}{\numberline {4.1.2.1}Correlation based identification of confounding factors}{82}{subsubsection.4.1.2.1}
\contentsline {subsubsection}{\numberline {4.1.2.2}Identification of immune cell types with enrichment test / other}{82}{subsubsection.4.1.2.2}
\contentsline {subsection}{\numberline {4.1.3}Transforming metagenes into signature matrix}{82}{subsection.4.1.3}
\contentsline {subsection}{\numberline {4.1.4}Regression-based estimation of cell-type proportions : solving system of equations}{82}{subsection.4.1.4}
\contentsline {section}{\numberline {4.2}\emph {DeconICA} R package for ICA-based deconvolution}{82}{section.4.2}
\contentsline {subsection}{\numberline {4.2.1}\emph {Demo}}{82}{subsection.4.2.1}
\contentsline {chapter}{\numberline {5}Comparative analysis of cancer immune infiltration}{99}{chapter.5}
\contentsline {chapter}{\numberline {6}Heterogeneity of immune cell types}{101}{chapter.6}
\contentsline {chapter}{\numberline {7}Conclusions and perspectives}{107}{chapter.7}
\contentsline {chapter}{Annexes}{109}{chapter*.28}
\contentsline {section}{PhD timeline for defence before the end of October 2018}{109}{section*.29}
\contentsline {section}{Thesis writing}{109}{section*.31}
\contentsline {section}{Activity Report 2017}{111}{section*.32}
